# Aldeyra Therapeutics (ALDX) — Earnings

ALDX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/aldx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.16 |
| EPS estimate | −$0.24 |
| EPS surprise | +33.33% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 7, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1341235/000095017025104971/aldx-20250630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/format/12a2684e-0e95-7457-b1e4-d09a46a082ee.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 7, 2025 | −$0.24 | −$0.16 | 33.33% | — | — |
| Q1 2025 | May 14, 2025 | −$0.28 | −$0.17 | 39.26% | — | — |
| Q4 2024 | Feb 28, 2025 | −$0.26 | −$0.27 | -2.54% | — | — |
| Q3 2024 | Nov 7, 2024 | −$0.25 | −$0.25 | -1.17% | — | — |
| Q2 2024 | Aug 1, 2024 | −$0.21 | −$0.28 | -35.72% | — | — |
| Q1 2024 | May 2, 2024 | −$0.11 | −$0.14 | -26.58% | $1.2M | — |
| Q4 2023 | Mar 7, 2024 | −$0.11 | −$0.08 | 27.60% | $3.0M | — |
| Q2 2023 | Aug 3, 2023 | −$0.17 | −$0.15 | 12.94% | — | — |
| Q1 2023 | May 4, 2023 | −$0.29 | −$0.27 | 6.99% | — | — |
| Q4 2022 | Mar 9, 2023 | −$0.31 | −$0.22 | 29.76% | — | — |
| Q3 2022 | Nov 10, 2022 | −$0.34 | −$0.25 | 27.26% | — | — |
| Q2 2022 | Aug 5, 2022 | −$0.31 | −$0.30 | 3.47% | — | — |
| Q1 2022 | May 5, 2022 | −$0.32 | −$0.29 | 7.94% | — | — |
| Q4 2021 | Mar 17, 2022 | −$0.28 | −$0.27 | 4.76% | — | — |
| Q3 2021 | Oct 28, 2021 | −$0.26 | −$0.27 | -2.70% | — | — |
| Q2 2021 | Aug 5, 2021 | −$0.24 | −$0.28 | -15.99% | — | — |
| Q1 2021 | May 6, 2021 | −$0.26 | −$0.25 | 5.16% | — | — |
| Q4 2020 | Mar 11, 2021 | −$0.28 | −$0.29 | -2.36% | — | — |
| Q3 2020 | Nov 5, 2020 | −$0.27 | −$0.23 | 15.00% | — | — |
| Q2 2020 | Aug 6, 2020 | −$0.35 | −$0.25 | 28.86% | — | — |

## Frequently Asked Questions

### When did Aldeyra Therapeutics (ALDX) last report earnings?

Aldeyra Therapeutics last reported on Aug 7, 2025, covering fiscal Q2 2025.

### Did ALDX beat earnings estimates?

Yes. Aldeyra Therapeutics reported EPS of −$0.16 for Q2 2025 against a −$0.24 estimate — a 33.33% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).